搜索医生

Derek R. Johnson, M.D.

  1. Neurologist
  2. Radiologist
预约门诊

出版物

  1. Zhu Y, Carabenciov DD, Johnson DR, Trejo-Lopez JA, Nguyen AT, Raghunathan A, Lanzino G, Ida CM, Zepeda-Mendoza CJ, Dasari S, Russler-Germain E, Dahiya S, Quezado M, Aldape K, Giannini C. Molecular profile of adult primary leptomeningeal gliomatosis aligns with glioblastoma, IDH-wildtype. Brain Pathol. 2024 Dec 18; e13326 [Epub ahead of print]
    View PubMed
  2. Mair MJ, Tabouret E, Johnson DR, Sulman EP, Wen PY, Preusser M, Albert NL. Radioligand therapies in meningioma: Evidence and future directions. Neuro Oncol. 2024 Dec 9; 26 (Supplement_9):S215-S228
    View PubMed
  3. Zeydan B, Johnson DR, Schwarz CG, Przybelski SA, Lesnick TG, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR Jr, Kantarci K, Lowe VJ. Visual assessments of 11 C-Pittsburgh compound-B PET vs. 18 F-flutemetamol PET across the age spectrum. Nucl Med Commun. 2024 Dec 1; 45 (12):1047-1054 Epub 2024 Sept 13
    View PubMed
  4. Mark IT, Van Gompel J, Celda MP, Stinson EG, Bancos I, Gruber LM, Little JT, Johnson DR, Messina SA. Contrast Enhanced CISS/FIESTA Imaging for Increased Conspicuity of Pituitary Microadenomas in Cushing Disease. AJNR Am J Neuroradiol. 2024 Nov 21 [Epub ahead of print]
    View PubMed
  5. Belge Bilgin G, Bilgin C, Orscelik A, Burkett BJ, Thorpe MP, Johnson DR, Johnson GB, Kallmes DF, Sartor O, Kendi AT. Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysis. Ann Nucl Med. 2024 Nov; 38 (11):865-876 Epub 2024 Sept 17
    View PubMed
  6. Bogsrud TV, Engelsen O, Lu TTT, Stensvold A, Johnson DR, Burkett BJ, Kendi AT, Pandey MK, Sundset R, Durski JM. All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [(177)Lu]Lu-PSMA-radioligand will be successful. EJNMMI Res. 2024 Oct 15; 14 (1):95
    View PubMed
  7. Albert NL, Preusser M, Traub-Weidinger T, Tolboom N, Law I, Palmer JD, Guedj E, Furtner J, Fraioli F, Huang RY, Johnson DR, Deroose CM, Herrmann K, Vogelbaum M, Chang S, Tonn JC, Weller M, Wen PY, van den Bent MJ, Verger A, Ivanidze J, Galldiks N. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0. Eur J Nucl Med Mol Imaging. 2024 Oct; 51 (12):3662-3679 Epub 2024 June 20
    View PubMed
  8. Belge Bilgin G, Burkett BJ, Bilgin C, Orme JJ, Childs DS, Rincon MM, Abdelrazek AS, Johnson DR, Johnson GB, Kwon ED, Sartor O, Kendi AT. Neurologic Symptoms After (177)Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience. J Nucl Med. 2024 Sep 3; 65 (9):1402-1408 Epub 2024 Sept 03
    View PubMed
  9. Ledet CB, Sener U, Johnson DR, Ku K, Halfdanarson TR. Fruquintinib-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Multiply Metastatic Rectal Cancer. Clin Colorectal Cancer. 2024 Sep 2 Epub 2024 Sept 02
    View PubMed
  10. Mark IT, Welker K, Erickson D, Johnson DR, Bathla G, Messina S, Farnsworth PJ, Van Gompel J. 7T MRI for Cushing Disease: A Single-Institution Experience and Literature Review. AJNR Am J Neuroradiol. 2024 Jul 8; 45 (7):971-976 Epub 2024 July 08
    View PubMed
  11. Mark IT, Van Gompel J, Bancos I, Nagelschneider AA, Johnson DR, Bathla G, Madhavan AA, Weber NM, Yu L. Back to the Future: Dynamic Contrast-Enhanced Photon-Counting Detector CT for the Detection of Pituitary Adenoma in Cushing Disease. AJNR Am J Neuroradiol. 2024 Jun 7; 45 (6):743-746 Epub 2024 June 07
    View PubMed
  12. Burkett BJ, Johnson DR, Lowe VJ. Evaluation of Neurodegenerative Disorders with Amyloid-beta, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls. J Nucl Med. 2024 Jun 3; 65 (6):829-837 Epub 2024 June 03
    View PubMed
  13. Donev K, Sundararajan V, Johnson D, Balan J, Chambers M, Paulson VA, Scherpelz KP, Abdullaev Z, Quezado M, Cimino PJ, Pratt D, Valerio E, Alves de Castro JV, Carraro DM, Torrezan GT, Wolff BM, Kulikowski LD, Costa FD, Aldape K, Ida CM. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered? J Neuropathol Exp Neurol. 2024 Apr 19; 83(5):357-364.
    View PubMed
  14. Benson JC, Trejo-Lopez JA, Cormier JL, Parney IF, Mark IT, Madhavan AA, Kotsenas AL, Rydberg CH, Luetmer PH, Eckel LJ, Johnson DR. Radiology-pathology correlation: Giant tumefactive perivascular spaces. Neuroradiol J. 2024 Apr 12; 19714009241247459 [Epub ahead of print]
    View PubMed
  15. Mendoza MA, Hass RM, Vaillant J, Johnson DR, Theel ES, Toledano M, Abu Saleh O. Powassan Virus Encephalitis: A Tertiary Center Experience. Clin Infect Dis. 2024 Jan 25; 78 (1):80-89
    View PubMed
  16. Galanis E, Dooley KE, Keith Anderson S, Kurokawa CB, Carrero XW, Uhm JH, Federspiel MJ, Leontovich AA, Aderca I, Viker KB, Hammack JE, Marks RS, Robinson SI, Johnson DR, Kaufmann TJ, Buckner JC, Lachance DH, Burns TC, Giannini C, Raghunathan A, Iankov ID, Parney IF. Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial. Nat Commun. 2024 Jan 12; 15 (1):493
    View PubMed
  17. Belge Bilgin G, Bilgin C, Childs DS, Orme JJ, Burkett BJ, Packard AT, Johnson DR, Thorpe MP, Riaz IB, Halfdanarson TR, Johnson GB, Sartor O, Kendi AT. Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer (177)Lu-PSMA-617 therapy. Front Oncol. 2024; 14:1386718 Epub 2024 July 12
    View PubMed
  18. Belge Bilgin G, Navin PJ, Johnson DR, Sartor O, Kendi AT. Acute pancreatitis and biliary obstruction from metastatic lymph node compression during [(177)Lu] Lu-PSMA-617 therapy: a case report. Front Oncol. 2024; 14:1442293 Epub 2024 Oct 07
    View PubMed
  19. Zeydan B, Johnson DR, Schwarz CG, Lee J, Przybelski SA, Lesnick TG, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR Jr, Kantarci K, Lowe VJ. Developing Topics. Alzheimers Dement. 2023 Dec; 19 Suppl 24:e082897
    View PubMed
  20. Burkett BJ, Johnson DR, Hunt CH, Messina SA, Broski SM. Anti-LGI1 Autoimmune Epilepsy. Clin Nucl Med. 2023 Nov 1; 48 (11):956-957 Epub 2023 Sept 07
    View PubMed
  21. Neth BJ, Raghunathan A, Kizilbash SH, Uhm JH, Breen WG, Johnson DR, Daniels DJ, Sener U, Carabenciov ID, Campian JL, Khatua S, Mahajan A, Ruff MW. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience. Neurology. 2023 Sep 19; 101 (12):e1256-e1271 Epub 2023 July 31
    View PubMed
  22. Mark IT, Black D, Benson JC, Campeau NG, Johnson DR, Messina SA, Giannini C, Parney I, Morris PP. Benign Enhancing Foramen Magnum Lesions. AJNR Am J Neuroradiol. 2023 Sep; 44 (9):999-1001 Epub 2023 Aug 03
    View PubMed
  23. Burkett BJ, Bartlett DJ, McGarrah PW, Lewis AR, Johnson DR, Berberoglu K, Pandey MK, Packard AT, Halfdanarson TR, Hruska CB, Johnson GB, Kendi AT. A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements. Radiol Imaging Cancer. 2023 Jul; 5 (4):e220157
    View PubMed
  24. Bauman MMJ, Graves JP, Harrison DJ, Hassett LC, Bancos I, Johnson DR, Van Gompel JJ. The utility of PET for detecting corticotropinomas in Cushing disease: a scoping review. Neurosurg Rev. 2023 Jul 1; 46 (1):160 Epub 2023 July 01
    View PubMed
  25. Ensign SF, Agarwal M, Klanderman M, Badawy M, Halfdanarson TR, Johnson DR, Sonbol MB, Kendi AT. Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesions. Nucl Med Commun. 2023 Jul 1; 44 (7):663-670 Epub 2023 May 08
    View PubMed
  26. Guerin JB, Kaufmann TJ, Eckel LJ, Morris JM, Vaubel RA, Giannini C, Johnson DR. A Radiologist's Guide to the 2021 WHO Central Nervous System Tumor Classification: Part 2-Newly Described and Revised Tumor Types. Radiology. 2023 Jun; 307 (5):e221885 Epub 2023 May 16
    View PubMed
  27. Camerucci E, Graff-Radford J, Jones DT, Elder BD, Gunter JL, Cutsforth-Gregory JK, Botha H, Murphy MC, Johnson DR, Davidge-Pitts C, Jack CR Jr, Huston J 3rd, Cogswell PM. Change in Morphological Features of Enlarged Subarachnoid Spaces Following Treatment in Idiopathic Normal Pressure Hydrocephalus. J Magn Reson Imaging. 2023 May; 57 (5):1443-1450 Epub 2022 July 27
    View PubMed
  28. Farnsworth PJ, Madhavan AA, Verdoorn JT, Shlapak DP, Johnson DR, Cutsforth-Gregory JK, Brinjikji W, Lehman VT. Spontaneous intracranial hypotension: updates from diagnosis to treatment. Neuroradiology. 2023 Feb; 65 (2):233-243 Epub 2022 Nov 07
    View PubMed
  29. Benson JC, Madhavan AA, Cutsforth-Gregory JK, Johnson DR, Carr CM. The Monro-Kellie Doctrine: A Review and Call for Revision. AJNR Am J Neuroradiol. 2023 Jan; 44 (1):2-6 Epub 2022 Dec 01
    View PubMed
  30. Vaubel RA, Kumar R, Weiskittel TM, Jenkins S, Dasari S, Uhm JH, Lachance DH, Brown PD, Van Gompel JJ, Jenkins RB, Kipp BR, Sukov WR, Giannini C, Johnson DR, Raghunathan A. Genomic markers of recurrence risk in atypical meningioma following gross total resection. Neurooncol Adv. 2023 Jan-Dec; 5 (1):vdad004 Epub 2023 Jan 10
    View PubMed
  31. Vizcaino MA, Giannini C, King RL, Johnson DR, Yang T, Raghunathan A. Primary Leptomeningeal Lymphoma: Clinicopathologic Features of 2 Rare Phenotypes. J Neuropathol Exp Neurol. 2022 Nov 16; 81 (12):1002-1007
    View PubMed
  32. Webb M, Johnson DR, Mahajan A, Brown P, Neth B, Kizilbash SH, Sener U. Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis. J Neurooncol. 2022 Nov; 160 (2):527-534 Epub 2022 Oct 27
    View PubMed
  33. Johnson DR, Giannini C, Vaubel RA, Morris JM, Eckel LJ, Kaufmann TJ, Guerin JB. A Radiologist's Guide to the 2021 WHO Central Nervous System Tumor Classification: Part I-Key Concepts and the Spectrum of Diffuse Gliomas. Radiology. 2022 Sep; 304 (3):494-508 Epub 2022 July 26
    View PubMed
  34. Burkett BJ, Babcock JC, Lowe VJ, Graff-Radford J, Subramaniam RM, Johnson DR. PET Imaging of Dementia: Update 2022. Clin Nucl Med. 2022 Sep 1; 47 (9):763-773 Epub 2022 May 12
    View PubMed
  35. Badawy M, Johnson G, Jain M, Kendi AT, Johnson DR, Porter A, Yang M, Sonbol MB. Intracranial neuroendocrine tumour simulating meningioma for several years: an overview of diagnosis and treatment. BJR Case Rep. 2022 Sep; 8(3):20210222. Epub 2022 Jan 27.
    View PubMed
  36. Carr CM, Benson JC, DeLone DR, Diehn FE, Kim DK, Ma D, Nagelschneider AA, Madhavan AA, Johnson DR. Manifestations of radiation toxicity in the head, neck, and spine: An image-based review. Neuroradiol J. 2022 Aug; 35(4):427-436. Epub 2022 May 01.
    View PubMed
  37. Babcock JC, Johnson DR, Benson JC, Kim DK, Luetmer PH, Shlapak DP, Cross CP, Johnson MP, Cutsforth-Gregory JK, Carr CM. Diffuse Calvarial Hyperostosis and Spontaneous Intracranial Hypotension: A Case-Control Study. AJNR Am J Neuroradiol. 2022 Jul; 43(7):978-983. Epub 2022 Jun 30.
    View PubMed
  38. Johnson DR, Glenn CA, Javan R, Olson JJ. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults. J Neurooncol. 2022 Jun; 158 (2):139-165 Epub 2021 Oct 25
    View PubMed
  39. Eschbacher KL, Johnson DR, Orozco-Do SL, Jawaid T, Schuetz AN, Nguyen AT. A 76-year-old male with multiple enhancing brain lesions. Brain Pathol. 2022 May; 32 (3):e13063 Epub 2022 Mar 10
    View PubMed
  40. Germano IM, Johnson DR, Patrick HH, Goodman AL, Ziu M, Ormond DR, Olson JJ. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Management of Progressive Glioblastoma in Adults: Update of the 2014 Guidelines. Neurosurgery. 2022 May 1; 90 (5):e112-e115
    View PubMed
  41. Neth BJ, Carabenciov ID, Ruff MW, Johnson DR. Temporal Trends in Glioblastoma Survival: Progress then Plateau. Neurologist. 2022 May 1; 27 (3):119-124 Epub 2022 May 01
    View PubMed
  42. Broski SM, Johnson DR, Packard AT, Hunt CH. (18)F-fluorodeoxyglucose PET/Computed Tomography: Head and Neck Salivary Gland Tumors. PET Clin. 2022 Apr; 17 (2):249-263 Epub 2022 Feb 26
    View PubMed
  43. Chatzopoulos K, Eschbacher KL, Gurram PR, Huang J, Rinaldo L, Milone AA, Johnson DR, Shah AS, Wengenack NL, Schuetz AN, Parney IF, Trejo-Lopez JA. An 82-year-old man with a right frontal lobe rim-enhancing lesion. Brain Pathol. 2022 Mar; 32 (2):e13021 Epub 2021 Oct 04
    View PubMed
  44. Benson JC, Eschbacher KL, Raghunathan A, Johnson D, Kim DK, Van Gompel J. Cavernous Sinus Vascular Venous Malformation. AJNR Am J Neuroradiol. 2022 Jan; 43 (1):19-23 Epub 2021 Nov 11
    View PubMed
  45. Schuelke MR, Gundelach JH, Coffey M, West E, Scott K, Johnson DR, Samson A, Melcher A, Vile RG, Bram RJ. Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors. Neurooncol Adv. 2022 Jan-Dec; 4 (1):vdac085 Epub 2022 June 17
    View PubMed
  46. Schroeder DG, Jang S, Johnson DR, Takahashi H, Navin PJ, Broski SM, Thorpe MP, Johnson GB, Young JR. Frequency and Characteristics of Nodal and Deltoid FDG and (11)C-Choline Uptake on PET Performed After COVID-19 Vaccination. AJR Am J Roentgenol. 2021 Nov; 217 (5):1206-1216 Epub 2021 May 19
    View PubMed
  47. Johnson BJ, Van Abel KM, Ma DJ, Johnson DR. (18)F-FDG-Avid Axillary Lymph Nodes After COVID-19 Vaccination. J Nucl Med 2021 Oct; 62 (10):1483-1484 Epub 2021 Mar 19
    View PubMed
  48. Parent EE, Johnson DR, Gleason T, Villanueva-Meyer JE. Neuro-Oncology Practice Clinical Debate: FDG PET to differentiate glioblastoma recurrence from treatment-related changes. Neurooncol Pract. 2021 Oct; 8 (5):518-525 Epub 2021 May 04
    View PubMed
  49. Ida CM, Johnson DR, Nair AA, Davila J, Kollmeyer TM, Minn K, Fadra NM, Balcom JR, Fung KA, Kim DK, Kaufmann TJ, Kipp BR, Halling KC, Jenkins RB, Giannini C. Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation. J Neuropathol Exp Neurol. 2021 Sep 27; 80 (9):821-829
    View PubMed
  50. Eschbacher KL, Ida CM, Johnson DR, Alvi MA, Jenkins SM, Ruff MW, Kerezoudis P, Neth BJ, Pasion RM, Daniels DJ, Kizilbash SH, Raghunathan A. Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity. Am J Surg Pathol. 2021 Aug 1; 45 (8):1082-1090
    View PubMed
  51. Johnson DR, Waid MD, Rula EY, Hughes DR, Rosenkrantz AB, Duszak R. Comparison of Radiologists and Other Specialists in the Performance of Lumbar Puncture Procedures Over Time. AJNR Am J Neuroradiol. 2021 Jun; 42 (6):1174-1181 Epub 2021 Mar 04
    View PubMed
  52. Zahid A, Mark IT, Gilbertson JR, Johnson DR. Cerebral malaria with extensive subcortical microhemorrhages. Oxf Med Case Reports. 2021 May; 2021 (5):omab028 Epub 2021 May 24
    View PubMed
  53. Carr CM, Benson JC, DeLone DR, Diehn FE, Kim DK, Merrell KW, Nagelschneider AA, Madhavan AA, Johnson DR. Intracranial long-term complications of radiation therapy: an image-based review. Neuroradiology. 2021 Apr; 63 (4):471-482 Epub 2021 Jan 04
    View PubMed
  54. Fogh SE, Boreta L, Nakamura JL, Johnson DR, Chi AS, Kurz SC. Neuro-Oncology Practice Clinical Debate: Early treatment or observation for patients with newly diagnosed oligodendroglioma and small-volume residual disease. Neurooncol Pract. 2021 Feb; 8 (1):11-17 Epub 2020 June 27
    View PubMed
  55. Zahid A, Johnson DR, Kizilbash SH. Efficacy of (177)Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb; 5 (1):236-240 Epub 2021 Jan 14
    View PubMed
  56. Johnson DR, Carr CM, Luetmer PH, Diehn FE, Lehman VT, Cutsforth-Gregory JK, Verdoorn JT, Krecke KN. Diffuse Calvarial Hyperostosis in Patients with Spontaneous Intracranial Hypotension. World Neurosurg. 2021 Feb; 146:e848-e853 Epub 2020 Nov 18
    View PubMed
  57. Muthusamy K, Hanna C, Johnson DR, Cramer CH, Tebben PJ, Libi SE, Poling GL, Lanpher BC, Morava E, Schimmenti LA. Growth hormone deficiency in a child with branchio-oto-renal spectrum disorder: Clinical evidence of EYA1 in pituitary development and a recommendation for pituitary function surveillance. Am J Med Genet A. 2021 Jan; 185 (1):261-266 Epub 2020 Oct 24
    View PubMed
  58. Stocksdale B, Nagpal S, Hixson JD, Johnson DR, Rai P, Shivaprasad A, Tremont-Lukats IW. Neuro-Oncology Practice Clinical Debate: long-term antiepileptic drug prophylaxis in patients with glioma. Neurooncol Pract. 2020 Dec; 7 (6):583-588 Epub 2020 May 20
    View PubMed
  59. Johnson GB, Harms HJ, Johnson DR, Jacobson MS. PET Imaging of Tumor Perfusion: A Potential Cancer Biomarker? Semin Nucl Med. 2020 Nov; 50 (6):549-561 Epub 2020 Aug 07
    View PubMed
  60. Neth BJ, Ruff MW, Uhm JH, Johnson DR, Divekar RD, Maddox DE. Temozolomide desensitization followed by metronomic dosing in patients with hypersensitivity. Cancer Chemother Pharmacol. 2020 Sep; 86 (3):375-382 Epub 2020 Aug 10
    View PubMed
  61. Jain R, Johnson DR, Patel SH, Castillo M, Smits M, van den Bent MJ, Chi AS, Cahill DP. "Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas. Neuro Oncol. 2020 Jul 7; 22 (7):936-943
    View PubMed
  62. Mark IT, Carr CM, Ruff MW, Flanagan EP, Johnson DR. Enlarging Perivascular Spaces Following Radiation Therapy in the Brain: A Report of 2 Cases and Literature Review. World Neurosurg. 2020 Jun; 138:436-439 Epub 2020 Apr 03
    View PubMed
  63. Palmer JD, Greenspoon J, Brown PD, Johnson DR, Roberge D. Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis. Neurooncol Pract. 2020 Jun; 7 (3):263-267 Epub 2019 Oct 01
    View PubMed
  64. Larson AS, Johnson DR, Lehman VT, Rinaldo L, Klaas J, Lanzino G, Savastano LE. Contemporary Management of Moyamoya Disease: Part II—Imaging Features and Grading Systems Contemporary Neurosurgery. 2020; 42(7):1-8. Epub 2020 Apr 30.
  65. Cogswell PM, Graff-Radford J, Wurtz LI, Graff-Radford NR, Johnson DR, Hunt CH, Gunter JL, Cutsforth-Gregory JK, Jones DT, Elder BD, Huston Iii J, Jack CR Jr. CSF dynamics disorders: Association of brain MRI and nuclear medicine cisternogram findings. Neuroimage Clin. 2020; 28:102481 Epub 2020 Oct 28
    View PubMed
  66. Johnson DR, Giannini C, Jenkins RB, Kim DK, Kaufmann TJ. Plenty of calcification: imaging characterization of polymorphous low-grade neuroepithelial tumor of the young. Neuroradiology. 2019 Nov; 61 (11):1327-1332 Epub 2019 Aug 09
    View PubMed
  67. Clark MS, Packard AT, Johnson DR, Johnson GB. Pitfalls of a Mixed Metabolic Response at PET/CT. Radiographics. 2019 Sep-Oct; 39 (5):1461-1475 Epub 2019 Aug 09
    View PubMed
  68. Black DF, Little JT, Johnson DR. Neuroanatomical Considerations in Preoperative Functional Brain Mapping. Top Magn Reson Imaging. 2019 Aug; 28 (4):213-224
    View PubMed
  69. Ehman , EC, Thompson , SM, Welch , BT, Johnson , DR, McGregor , HCJ. PET Imaging of Helatocellular Carcinoma Cur Radiol Rep. 2019.
  70. Johnson DR, Kaufmann TJ, Patel SH, Chi AS, Snuderl M, Jain R. There is an exception to every rule-T2-FLAIR mismatch sign in gliomas. Neuroradiology. 2019 Feb; 61 (2):225-227 Epub 2018 Dec 18
    View PubMed
  71. Johnson DR, Guerin JB, Ruff MW, Fang S, Hunt CH, Morris JM, Morris PP, Pearse Morris P, Kaufmann TJ. Glioma response assessment: Classic pitfalls, novel confounders, and emerging imaging tools. Br J Radiol. 2019 Feb; 92 (1094):20180730 Epub 2018 Nov 14
    View PubMed
  72. Cerhan JH, Caine C, Anderson SK, Johnson DR, Lachance DH, Yan E, Brown PD. Preliminary exploration of a computerized cognitive battery and comparison with traditional testing in patients with high-grade glioma. Neurooncol Pract. 2019 Jan; 6 (1):71-77 Epub 2018 May 21
    View PubMed
  73. Ruff MW, Buckner JC, Johnson DR, van den Bent MJ, Geurts M. Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma. Neurooncol Pract. 2019 Jan; 6 (1):17-21 Epub 2018 Nov 03
    View PubMed
  74. Cachia D, Johnson DR, Kaufmann TJ, Lowe S, Andersen S, Olar A, Cooper SL, Frankel BM, Gilbert MR. Case-based review: ependymomas in adults. Neurooncol Pract. 2018 Aug; 5 (3):142-153 Epub 2018 July 24
    View PubMed
  75. Ruff MW, Carabenciov ID, Johnson DR, Pollock BE, Parisi JE, Klaas JP. A cavernous sinus lesion clinically responsive to steroids. J Clin Neurosci. 2018 Jul; 53:239-240 Epub 2018 Apr 21
    View PubMed
  76. Johnson DR, Omuro AMP, Ravelo A, Sommer N, Guerin A, Ionescu-Ittu R, Shi S, Macalalad A, Uhm JH. Overall survival in patients with glioblastoma before and after bevacizumab approval. Curr Med Res Opin. 2018 May; 34 (5):813-820 Epub 2017 Nov 10
    View PubMed
  77. Johnson DR, Hunt CH, Nathan MA, Parisi JE, Boeve BF, Murray ME, Knopman DS, Jack CR Jr, Petersen RC, Lowe VJ, Johnson GB. Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors. J Neurooncol. 2018 Jan; 136 (2):373-378 Epub 2017 Nov 08
    View PubMed
  78. Johnson DR, Campeau NG. Dual-Energy CT Differentiates Contrast Staining From Hemorrhagic Conversion of Ischemic Stroke. Neurohospitalist. 2018 Jan; 8 (1):42-43 Epub 2017 Apr 16
    View PubMed
  79. Bruinsma TJ, Johnson DR, Fang P, Senjem M, Josephs KA, Whitwell JL, Boeve BF, Pandey MK, Kantarci K, Jones DT, Vemuri P, Murray M, Graff-Radford J, Schwarz CG, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ. Uptake of AV-1451 in meningiomas. Ann Nucl Med. 2017 Dec; 31 (10):736-743 Epub 2017 Sept 08
    View PubMed
  80. Johnson DR, Guerin JB, Giannini C, Morris JM, Eckel LJ, Kaufmann TJ. 2016 Updates to the WHO Brain Tumor Classification System: What the Radiologist Needs to Know. Radiographics. 2017 Nov-Dec; 37 (7):2164-2180 Epub 2017 Oct 13
    View PubMed
  81. Graffeo CS, Leeper HE, Perry A, Uhm JH, Lachance DJ, Brown PD, Ma DJ, Van Gompel JJ, Giannini C, Johnson DR, Raghunathan A. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma. World Neurosurg. 2017 Jul; 103:655-663 Epub 2017 Apr 24
    View PubMed
  82. Kalina P, Guerin JB, Johnson DR, Koch BL, Merrow AC, O'Brien WT. Pediatric Parotid Region Lesions: An imaging Review Neurographics. 2017; 33(1852).
  83. Johnson DR, Diehn FE, Giannini C, Jenkins RB, Jenkins SM, Parney IF, Kaufmann TJ. Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI. AJNR Am J Neuroradiol. 2017 Apr; 38 (4):678-684 Epub 2017 Jan 26
    View PubMed
  84. Maloney PR, Yamaki VN, Kumar R, Johnson D, Hunt C, Jentoft ME, Clarke M. Osteosclerosis Secondary to Metastatic Oligodendroglioma. Rare Tumors. 2017 Mar 24; 9 (1):6837 Epub 2017 Mar 31
    View PubMed
  85. Korfel A, Schlegel U, Johnson DR, Kaufmann TJ, Giannini C, Hirose T. Case-based review: primary central nervous system lymphoma. Neurooncol Pract. 2017 Mar; 4 (1):46-59 Epub 2017 Feb 09
    View PubMed
  86. Fogh SE, Johnson DR, Barker FG 2nd, Brastianos PK, Clarke JL, Kaufmann TJ, Oberndorfer S, Preusser M, Raghunathan A, Santagata S, Theodosopoulos PV. Case-Based Review: meningioma. Neurooncol Pract. 2016 Jun; 3 (2):120-134 Epub 2016 Jan 13
    View PubMed
  87. Johnson DR, Fogh SE, Giannini C, Kaufmann TJ, Raghunathan A, Theodosopoulos PV, Clarke JL. Case-Based Review: newly diagnosed glioblastoma. Neurooncol Pract. 2015 Sep; 2 (3):106-121 Epub 2015 July 21
    View PubMed
  88. Porter AB, Lachance DH, Johnson DR. Socioeconomic status and glioblastoma risk: a population-based analysis. Cancer Causes Control. 2015 Feb; 26 (2):179-185 Epub 2014 Nov 25
    View PubMed
  89. Johnson DR, Galanis E. Medical management of high-grade astrocytoma: current and emerging therapies. Semin Oncol. 2014 Aug; 41 (4):511-522 Epub 2014 June 30
    View PubMed
  90. Johnson DR, Leeper HE, Uhm JH. Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: a population-based analysis. Cancer. 2013 Oct 1; 119 (19):3489-95 Epub 2013 July 18
    View PubMed
  91. Johnson DR, Wefel JS. Relationship between cognitive function and prognosis in glioblastoma. CNS Oncol. 2013 Mar; 2 (2):195-201
    View PubMed
  92. Johnson DR, Galanis E. Incorporation of prognostic and predictive factors into glioma clinical trials. Curr Oncol Rep. 2013 Feb; 15 (1):56-63
    View PubMed
  93. Johnson DR, O'Neill BP, Decker PA, Kosel ML, Lanzino G, Hammack JE. Mortality and discharge to home after closed brain biopsy: analysis of 3523 cases from the State of California, 2003-2009. World Neurosurg. 2013 Jan; 79: (1)110-5.
    View PubMed
  94. Johnson DR, Ma DJ, Buckner JC, Hammack JE. Conditional probability of long-term survival in glioblastoma: a population-based analysis. Cancer. 2012 Nov 15; 118 (22):5608-13 Epub 2012 May 08
    View PubMed
  95. Johnson DR, Kaufmann TJ. Rapid symptomatic and radiographic evolution after presumed spontaneous infarction of a meningioma. Neurologist. 2012 Nov; 18(6):409-12.
    View PubMed
  96. Kamel H, Johnson DR, Hegde M, Go AS, Sidney S, Sorel M, Hills NK, Johnston SC. Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):726-31. Epub 2011 May 05.
    View PubMed
  97. Johnson DR, Sawyer AM, Meyers CA, O'Neill BP, Wefel JS. Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma. Neuro Oncol. 2012 Jun; 14 (6):808-16 Epub 2012 Apr 16
    View PubMed
  98. Johnson DR, Brown PD, Galanis E, Hammack JE. Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol. 2012 May; 108 (1):187-93 Epub 2012 Feb 25
    View PubMed
  99. Johnson DR, O'Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2012 Apr; 107 (2):359-64 Epub 2011 Nov 02
    View PubMed
  100. Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, Davis F, McCarthy B, Rynearson AL, Worra JB, Fridley BL, O'Neill BP, Buckner JC, Il'yasova D, Jenkins RB, Wrensch MR. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol. 2011 Sep 1; 174 (5):574-81 Epub 2011 July 08
    View PubMed
  101. Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, Folsom AR, Virnig BA, Cerhan JR. Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study. Neuro Oncol. 2011 Sep; 13 (9):1011-9 Epub 2011 July 12
    View PubMed
  102. Johnson DR, Kimmel DW, Burch PA, Cascino TL, Giannini C, Wu W, Buckner JC. Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. Neuro Oncol. 2011 May; 13 (5):530-5
    View PubMed
  103. Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y, Kollmeyer TM, Rynearson AL, Fink S, Rice T, McCoy LS, Halder C, Kosel ML, Giannini C, Tihan T, O'Neill BP, Lachance DH, Yang P, Wiemels J, Wiencke JK. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet. 2011 Jan; 204 (1):13-8
    View PubMed
  104. Kamel H, Hegde M, Johnson DR, Gage BF, Johnston SC. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke. 2010 Jul; 41(7):1514-20. Epub 2010 May 27.
    View PubMed
PST-20536770